|
시장보고서
상품코드
2050769
이식 진단 시장 : 제품 유형별, 기술별, 용도별, 장기 유형별, 최종사용자별, 지역별Transplant Diagnostics Market, By Product Type, By Technology, By Application, By Organ Type, By End User, By Geography |
||||||
이식 진단 시장은 2026년에 12억 2,590만 달러로 추정되고, 2033년에 21억 5,600만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 8.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 12억 2,590만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.40% | 2033년 시장 규모 예측 : | 21억 5,600만 달러 |
이식 진단 분야는 장기 이식 절차에 혁명을 일으켜 장기 및 조직 이식의 적합성과 성공률을 높이는 데 중요한 역할을 해왔습니다. 세계 이식 진단 시장은 기증된 장기 및 조직과 수혜자의 면역 체계의 적합성을 확인하는 데 사용되는 다양한 의료 절차, 기술, 검사, 장비와 관련되어 있습니다. 이 의료 부문은 이식 거부반응의 가능성을 줄이고 이식 후 환자의 예후를 개선하는 데 있어 매우 중요한 역할을 하고 있습니다. 이식 진단에는 기증자와 수혜자의 최적의 적합성을 보장하기 위해 매우 중요한 인간 백혈구 항원(HLA) 타이핑과 같은 조직 적합성 검사를 포함한 일련의 검사가 포함됩니다. 이 외에도 장기 거부반응을 일으킬 수 있는 항체를 평가하기 위해 혈청학적 검사나 유전체 기반 검사 등이 사용되고 있습니다. 중합효소연쇄반응(PCR), 차세대염기서열분석(NGS) 등의 첨단 분자진단 검사는 유전적 적합성에 대한 상세한 정보를 제공하여 장기의 적합성 및 생존가능성 평가를 향상시킵니다. 또한, 새로운 진단 기술의 등장, 장기 이식이 필요한 암과 같은 만성 질환의 발생률 증가, 이식 수술 건수 증가, 이러한 의료 행위에 대한 인식 증가와 자금 지원의 확대가 세계 이식 진단 시장의 확대에 기여하고 있습니다. 또한, 새로운 진단 검사에 대한 규제 당국의 승인과 장기 기증을 촉진하기 위한 다양한 정부 및 비정부기구의 참여도 시장 성장을 견인하는 요인으로 작용하고 있습니다. 이 시장은 수많은 의료기기 제조업체, 전문 진단센터, 연구기관이 제공하는 다양한 검사 서비스 및 장비로 구성되어 있으며, 급성 및 만성 장기 부족을 해결하고 효과적인 이식 결과를 보장하고 있습니다. 향후 지속적인 연구개발과 더불어 맞춤형 의료의 보급과 개발도상국의 의료비 증가는 이식진단 시장을 더욱 촉진할 것으로 예측됩니다. 첨단 진단기술의 등장과 예방의료에 대한 관심이 높아지면서 이 시장은 지속적인 성장과 진화를 거듭할 것으로 보입니다.
시장 역학
세계 이식 진단 시장은 전 세계 장기부전 발생률 증가와 장기 이식 수술 건수 증가에 의해 주도되고 있습니다. 예를 들어, 연방정부와의 계약에 따라 미국 전역의 장기 기증 및 이식 네트워크 역할을 하는 '장기 공유 네트워크(UNOS)'의 속보 데이터에 따르면, 2022년 미국에서 4만 2,887건의 장기 이식이 이뤄져 2021년 대비 3.7% 증가해 연간 사상 최고치를 기록했습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 이식 진단 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계 이식 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 이식 진단 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 이식 진단 시장 : 제품 유형별, 2021-2033년
제5장 세계의 이식 진단 시장 : 기술별, 2021-2033년
제6장 세계의 이식 진단 시장 : 용도별, 2021-2033년
제7장 세계의 이식 진단 시장 : 장기 유형별, 2021-2033년
제8장 세계의 이식 진단 시장 : 최종사용자별, 2021-2033년
제9장 세계의 이식 진단 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
LSH 26.06.12Transplant Diagnostics Market is estimated to be valued at USD 1,225.9 Mn in 2026 and is expected to reach USD 2,156.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,225.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.40% | 2033 Value Projection: | USD 2,156 Mn |
The field of transplant diagnostics has been instrumental in revolutionizing organ transplant procedures, enhancing the compatibility and success rate of organ and tissue grafts. The global market for transplant diagnostics pertains to the extensive range of medical procedures, technologies, tests, and equipment used to ascertain the compatibility of donated organs and tissues with the recipient's immune system. This branch of medical science plays a critical role in reducing the likelihood of transplant rejection and improving patient outcomes post-transplantation. Transplant diagnostics involve a series of tests that include histocompatibility testing, such as human leukocyte antigens (HLA) typing, which is pivotal in ensuring the most compatible match between donor and recipient. This is further supported by serological and genome-based assays used to assess antibodies that may cause organ rejection. Advanced molecular diagnostic tests such as polymerase chain reaction (PCR) and Next-Generation Sequencing (NGS) offer detailed insights into the genetic matching, improving the precision of organ matches and viability assessments. Furthermore, the emergence of new diagnostic technologies, the increasing incidence of chronic diseases such as cancer, necessitating organ transplants, a growing number of transplantation procedures, and heightened awareness and funding for such medical practices have contributed to the expansion of the global transplant diagnostics market. Additionally, regulatory approvals for new diagnostic tests, along with the involvement of various government and non-governmental organizations in promoting organ donation, are factors driving market growth. The market comprises various testing services and instruments provided by numerous medical device companies, specialty diagnostic centers, and research labs, addressing acute and chronic organ shortages and ensuring effective transplant outcomes. Moving forward, the continued research and development, coupled with the rising adoption of personalized medicine and increased healthcare spending in developing countries, are expected to bolster the transplant diagnostics market further. With the advent of sophisticated diagnostic technologies and a growing emphasis on preventive healthcare, the market is set for continued growth and evolution.
Market Dynamics
The global transplant diagnostics market is driven by the rising incidence of organ failure and increasing organ transplantation procedures worldwide. For instance, in 2022, 42,887 organ transplants were performed in the U.S., an increase of 3.7 percent over 2022 and a new annual record, according to preliminary data from the United Network for Organ Sharing (UNOS), which serves as the national Organ Procurement and Transplantation Network under federal contract.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global transplant diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffman-La Roche Ltd., Immucor, Inc., Becton Dickinson and Company, bioMerieux S.A., Illumina, Inc., CareDx, Inc., and GenDx.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics
- The global transplant diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transplant diagnostics market
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021 - 2033)
- Instrument
- Reagents & Kits
- Software
- By Technology (Revenue, USD Mn, 2021 - 2033)
- Molecular Assay
- Non-Molecular Assay
- By Application (Revenue, USD Mn, 2021 - 2033)
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type (Revenue, USD Mn, 2021 - 2033)
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players Insights
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Hoffman-La Roche Ltd.
- Immucor, Inc.
- Becton Dickinson and Company
- bioMerieux S.A.
- Illumina, Inc.
- CareDx, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Transplant Diagnostics, By Product Type
- Market Transplant Diagnostics, By Technology
- Market Transplant Diagnostics, By Application
- Market Transplant Diagnostics, By Organ Type
- Market Transplant Diagnostics, By End User
- Market Transplant Diagnostics, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising number of organ transplantation
- Restraints
- High cost of transplant diagnostic tests
- Opportunities
- Point-of-care transplant diagnostics
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Transplant Diagnostics Market, By Product Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Instrument
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Transplant Diagnostics Market, By Technology, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Molecular Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Non-Molecular Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Transplant Diagnostics Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Tissue Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Serum-Cross Matching
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Blood Profiling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Transplant Diagnostics Market, By Organ Type , 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Kidney
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Liver
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Heart
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Pancreas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
8. Global Transplant Diagnostics Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals & Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Research Laboratories & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Commercial Service Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
9. Global Transplant Diagnostics Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Organ Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
- South Africa
- Central Africa
- North Africa
10. Competitive Landscape
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hoffman-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Immucor, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- bioMerieux S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CareDx, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GenDx
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
